Bohai

Bohai Pharmaceuticals Group, Inc.

Bohai Pharmaceuticals Group, Inc.

(OTC: BOPH)

Corporate website • Investor Presentation_2014.7.28

A manufacturer and marketer of traditional Chinese medicine (TCM) in the People’s Republic of China, Bohai offers seven varieties of approved herbal medicines comprising four prescription drugs and three over-the-counter products in six delivery systems. The company reported net income of USD $21.9 million, or $1.22 per share, on revenue of USD $175.1 million for the year ended June 30, 2014.